相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of depatuxizumab mafodotin plus temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial
Andrew B. Lassman et al.
NEURO-ONCOLOGY (2019)
Antibody-drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study
Suzanne Trudel et al.
BLOOD CANCER JOURNAL (2019)
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study
S. Banerjee et al.
ANNALS OF ONCOLOGY (2018)
40INA novel drug conjugate platform: Redefining the therapeutic window for ADCs
J Babcook et al.
ANNALS OF ONCOLOGY (2018)
Synthesis and evaluation of novel dolastatin 10 derivatives for versatile conjugations
Shinya Yokosaka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates
James W. Purcell et al.
CANCER RESEARCH (2018)
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas
John A. Thompson et al.
CLINICAL CANCER RESEARCH (2018)
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
Andrew C. Phillips et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified Metabolite
Josh T. Snyder et al.
MOLECULAR PHARMACEUTICS (2018)
Toward aplyronine payloads for antibody-drug conjugates: total synthesis of aplyronines A and D
Nika Anzicek et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2018)
MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity
Xin Cheng et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Current Status of Marine-Derived Compounds as Warheads in Anti-Tumor Drug Candidates
David J. Newman et al.
MARINE DRUGS (2017)
Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates
Magdalena Dorywalska et al.
BIOCONJUGATE CHEMISTRY (2015)
A phase 2 study of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following abiraterone and/or enzalutamide (abi/enz).
Daniel Peter Petrylak et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Biological targets and mechanisms of action of natural products from marine cyanobacteria
Lilibeth A. Salvador-Reyes et al.
NATURAL PRODUCT REPORTS (2015)
Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy
Magdalena Dorywalska et al.
PLOS ONE (2015)
Probody therapeutics for targeting antibodies to diseased tissue
Krishna R. Polu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
Django Sussman et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
Pavel Strop et al.
CHEMISTRY & BIOLOGY (2013)
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates
Diego A. Gianolio et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Antineoplastic Agents. 592. Highly Effective Cancer Cell Growth Inhibitory Structural Modifications of Dolastatin 10
George R. Pettit et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin
Galina Kuznetsov et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Phase II trial of dolastatin-10 in patients with advanced breast cancer
EA Perez et al.
INVESTIGATIONAL NEW DRUGS (2005)
Marine natural products and related compounds in clinical and advanced preclinical trials
DJ Newman et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Advanced preclinical and clinical trials of natural products and related compounds from marine sources
DJ Newman et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
分享论文
